European Commission decides that Cranberry-Derived Products are not Medical Devices

The European Commission released a draft decision meaning that the group of products which depends on proanthocyanidins which can be found in cranberry (Vaccinium Macrocarpon) extract, in order to prevent or treat cystitis, also known as bladder inflammation or infection, should not be classified as medical devices.

The legal basis for this measure is Article 13 (1) (d) of the Medical Devices Directive (Council Directive 93/42/EEC of 14 June 1993 on medical devices).

In particular, this Article allows the Commission to take a decision, at a request of a Member State, on whether a product or product group falls within a definition of a ‘medical device’ from Article 1 (2) (d) of the Medical Devices Directive.

To read more about this and to view the article please click here.

 

Tagged with

Published on 1. March 2016 in News EU